RMED
Income statement / Annual
Last year (2024), Ra Medical Systems, Inc.'s total revenue was $420.00 K,
an increase of 2,900.00% from the previous year.
In 2024, Ra Medical Systems, Inc.'s net income was -$21.80 M.
See Ra Medical Systems, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2024 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$420.00 K |
$14.00 K |
$22.00 K |
$4.41 M |
$7.20 M |
$6.26 M |
$5.87 M |
$5.98 M |
| Cost of Revenue |
$42.00 K
|
$161.00 K
|
$1.56 M
|
$5.48 M
|
$8.85 M
|
$4.21 M
|
$4.17 M
|
$3.14 M
|
| Gross Profit |
$378.00 K
|
-$147.00 K
|
-$1.54 M
|
-$1.08 M
|
-$1.65 M
|
$2.05 M
|
$1.71 M
|
$2.84 M
|
| Gross Profit Ratio |
0.9
|
-10.5
|
-69.91
|
-0.24
|
-0.23
|
0.33
|
0.29
|
0.47
|
| Research and Development Expenses |
$272.00 K
|
$6.39 M
|
$12.25 M
|
$9.01 M
|
$4.53 M
|
$2.78 M
|
$4.52 M
|
$1.72 M
|
| General & Administrative Expenses |
$0.00
|
$2.23 M
|
$0.00
|
$0.00
|
$0.00
|
$30.44 M
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$1.25 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$11.35 M
|
$16.25 M
|
$15.48 M
|
$25.97 M
|
$51.55 M
|
$30.44 M
|
$14.95 M
|
$5.32 M
|
| Other Expenses |
$0.00
|
$99.00 K
|
$0.00
|
$21.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$11.62 M
|
$22.64 M
|
$27.73 M
|
$34.98 M
|
$56.08 M
|
$33.21 M
|
$19.47 M
|
$7.04 M
|
| Cost And Expenses |
$11.66 M
|
$22.80 M
|
$29.29 M
|
$40.46 M
|
$64.93 M
|
$37.42 M
|
$23.63 M
|
$10.17 M
|
| Interest Income |
$81.00 K
|
$0.00
|
$0.00
|
$129.00 K
|
$1.04 M
|
$352.00 K
|
$0.00
|
$0.00
|
| Interest Expense |
-$91.00 K
|
$3.08 M
|
$0.00
|
$108.00 K
|
$250.00 K
|
$14.00 K
|
$4.00 K
|
$3.00 K
|
| Depreciation & Amortization |
$0.00
|
$8.77 M
|
$1.57 M
|
$2.37 M
|
$1.75 M
|
$624.00 K
|
$218.00 K
|
$95.00 K
|
| EBITDA |
-$11.24 M |
-$18.20 M |
-$29.27 M |
-$33.57 M |
-$54.94 M |
-$31.16 M |
-$17.54 M |
-$4.10 M |
| EBITDA Ratio |
-26.77
|
-1299.71
|
-1330.27
|
-7.62
|
-7.63
|
-4.98
|
-2.99
|
-0.69
|
| Operating Income Ratio |
-26.77
|
-1925.79
|
-1330.27
|
-8.19
|
-8.02
|
-4.98
|
-3.03
|
-0.7
|
| Total Other Income/Expenses Net |
-$2.26 M
|
$3.00 K
|
$2.01 M
|
$21.00 K
|
$788.00 K
|
$338.00 K
|
-$4.00 K
|
-$3.00 K
|
| Income Before Tax |
-$13.50 M
|
-$26.86 M
|
-$27.26 M
|
-$36.04 M
|
-$56.94 M
|
-$30.82 M
|
-$17.76 M
|
-$4.20 M
|
| Income Before Tax Ratio |
-32.15
|
-1918.71
|
-1238.95
|
-8.18
|
-7.91
|
-4.93
|
-3.03
|
-0.7
|
| Income Tax Expense |
$3.14 M
|
$3.00 K
|
$4.00 K
|
$7.00 K
|
$15.00 K
|
$10.00 K
|
$1.00 K
|
$1.00 K
|
| Net Income |
-$21.80 M
|
-$26.87 M
|
-$27.26 M
|
-$36.05 M
|
-$56.96 M
|
-$30.83 M
|
-$17.77 M
|
-$4.20 M
|
| Net Income Ratio |
-51.91
|
-1918.93
|
-1239.14
|
-8.18
|
-7.91
|
-4.93
|
-3.03
|
-0.7
|
| EPS |
-6.68 |
-25.98 |
-269.91 |
-1060.77 |
-5416.22 |
-4175.51 |
-1834.66 |
-433.96 |
| EPS Diluted |
-6.68 |
-25.98 |
-269.91 |
-1060.77 |
-5416.22 |
-4175.51 |
-1834.66 |
-433.96 |
| Weighted Average Shares Out |
$3.26 M
|
$1.03 M
|
$101.00 K
|
$33.98 K
|
$10.52 K
|
$7.38 K
|
$9.68 K
|
$9.68 K
|
| Weighted Average Shares Out Diluted |
$3.26 M
|
$1.03 M
|
$101.00 K
|
$33.98 K
|
$10.52 K
|
$7.38 K
|
$9.68 K
|
$9.68 K
|
| Link |
|
|
|
|
|
|
|
|
